Search Results - "POSTHUMA, E. F. M."

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry by Dinmohamed, A G, van Norden, Y, Visser, O, Posthuma, E F M, Huijgens, P C, Sonneveld, P, van de Loosdrecht, A A, Jongen-Lavrencic, M

Get full text

HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia by Rutten, C E, van Luxemburg-Heijs, S A P, Griffioen, M, Marijt, E W A, Jedema, I, Heemskerk, M H M, Posthuma, E F M, Willemze, R, Falkenburg, J H F

“…Mismatching for human leukocyte antigen (HLA)-DPB1 in unrelated donor hematopoietic stem cell transplantation (URD-SCT) has been associated with a decreased…”
Get full text

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study by Holtzer-Goor, K. M., Schaafsma, M. R., Joosten, P., Posthuma, E. F. M., Wittebol, S., Huijgens, P. C., Mattijssen, E. J. M., Vreugdenhil, G., Visser, H., Peters, W. G., Erjavec, Z., Wijermans, P. W., Daenen, S. M. G. J., van der Hem, K. G., van Oers, M. H. J., Uyl-de Groot, C. A.

“…Purpose To describe the health-related quality of life (HRQoL) of an unselected population of patients with chronic lymphocytic leukaemia (CLL) including…”
Get full text

Chronic Lymphocytic Leukaemia in the Netherlands: Trends in incidence, treatment and survival, 1989–2008 by van den Broek, E.C, Kater, A.P, van de Schans, S.A.M, Karim-Kos, H.E, Janssen-Heijnen, M.L.G, Peters, W.G, Nooijen, P.T.G.A, Coebergh, J.W.W, Posthuma, E.F.M

“…Abstract We present trends in incidence, early treatment and survival of Chronic Lymphocytic Leukaemia (CLL) between 1989 and 2008, based on population-based…”
Get full text

Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both? by van den Broek, E. C., Liu, L., Posthuma, E. F. M., Janssen-Heijnen, M. L. G., Coebergh, J. W. W., Soerjomataram, I.

“…We assessed the risk of chronic lymphocytic leukaemia (CLL) following earlier primary malignancies (EPM) to explore the extent and determinants of this risk…”
Get full text

Improved survival for patients with large B-cell lymphoma after introduction of rituximab by RODENBURG, E. M, MAARTENSE, E, POSTHUMA, E. F. M

“…To determine whether the reported increase in survival of patients with diffuse large B-cell malignant lymphoma (DLBCL) after the introduction of rituximab is…”
Get full text

Pulmonary coccidioidomycosis: import illness and the importance of travel history by INDHIRAJANTI, S, MAARTENSE, E, POSTHUMA, E. F. M, PANNEKOEK, B. J. M, VREEDE, R. W

“…A 35-year-old man presented at the outpatient department of pulmonary diseases with fever, rhinitis and coughing. He had recently been on holiday in…”
Get full text

Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level by AGTEROF, M. J., SCHUTGENS, R. E. G., SNIJDER, R. J., EPPING, G., PELTENBURG, H. G., POSTHUMA, E. F. M., HARDEMAN, J. A., VAN DER GRIEND, R., KOSTER, T., PRINS, M. H., BIESMA, D. H.

“…Background: Low NT‐proBNP levels are associated with an uncomplicated course in patients with pulmonary embolism (PE). The aim of this multicenter management…”
Get full text

Splenectomy-induced long-term remission in a patient with multicentric Castleman's disease by BOS, M. M. E. M, VAN DEN BERG, L. M, VAN LEEUWEN, A. W. F. M, POSTHUMA, E. F. M

“…Castleman's disease (CD) is a rare lymphoproliferative disorder with a poorly understood pathogenesis. Multicentric CD can progress in different patterns, none…”
Get full text

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands by Blommestein, Hedwig M, Groot, Saskia de S, Aarts, Mieke J, Vemer, Pepijn, Vries, Robin De, Abeelen, Annet FMVan, Posthuma, EFMWard, Groot, Carin AUyl-de

“…Highlights • GClb appeared to be a cost-effective treatment strategy compared to RClb and Clb • The ICERs of GClb compared to RClb and Clb were €23,208 and…”
Get full text

The beneficial local and abscopal effect of splenic irradiation in frail patients with chronic lymphocytic leukaemia by Aalbers, A M, Aarts, M J, Krol, A D G, Marijnen, C A M, Posthuma, E F M

“…Chronic lymphocytic leukaemia (CLL) is a common haematological malignancy that mainly occurs in the elderly population. Patients frequently have comorbidities…”
Get full text

HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML) by POSTHUMA, E. F. M, FALKENBURG, J. H. F, ROOSNEK, E, NIEDERWIESER, D, APPERLEY, J. F, GRATWOHL, A, HERTENSTEIN, B, SCHIPPER, R. F, OUDSHOORN, M, BIEZEN, J. V, HERMANS, J, WILLEMZE, R

“…CML is characterized by the chromosomal translocation t(9;22) (q34;q11) resulting in the chimeric bcr-abl oncogene that encodes P210 fusion proteins with novel…”
Get full text

Risk of male breast cancer after Hodgkin lymphoma by de Vries, Simone, Krul, Inge M, Schaapveld, Michael, Janus, Cecile P M, Rademakers, Saskia E, Roesink, Judith M, Nijziel, Marten R, Bilgin, Yavuz M, Aleman, Berthe M P, van Leeuwen, Flora E

“…Female survivors of Hodgkin lymphoma (HL) treated with chest radiotherapy have a strongly increased risk of breast cancer (BC), but the treatment-specific BC…”
Get full text

Differences in Magnitude and Duration of Opioid-Induced Respiratory Depression and Analgesia with Fentanyl and Sufentanil by Bailey, Peter L., Streisand, James B., East, Katherine A., East, Thomas D., Isern, Sandra, Hansen, Timothy W., Posthuma, E. F. M., Rozendaal, F. Wim, Pace, Nathan L., Stanley, Theodore H.

“…The magnitude and duration of analgesia and respiratoy depression induced by fentanyl (1.0, 2.0, and 4.0 μg/kg) and sufentanil (0.1, 0.2, and 0.4 μg/kg) after…”
Get full text

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma by Geurts, Y.M., Neppelenbroek, S.I.M., Aleman, B.M.P., Janus, C.P.M., Krol, A.D.G., van Spronsen, D.J., Plattel, W.J., Roesink, J.M., Verschueren, K.M.S., Zijlstra, J.M., Koene, H.R., Nijziel, M.R., Schimmel, E.C., de Jongh, E., Ong, F., te Boome, L.C.J., van Rijn, R.S., Böhmer, L.H., Ta, B.D.P., Visser, H.P.J., Posthuma, E.F.M., Bilgin, Y.M., Muller, K., van Kampen, D., So-Osman, C., Vermaat, J.S.P., de Weijer, R.J., Kersten, M.J., van Leeuwen, F.E., Schaapveld, M.

“…The introduction of rituximab significantly improved the prognosis of diffuse large B-cell lymphoma (DLBCL), emphasizing the importance of evaluating the…”
Get full text

Myelofibrosis and idiopathic thrombocytopenic purpura by SEELEN, M. A. J, DE MEIJER, P. H. E. M, POSTHUMA, E. F. M, MEINDERS, A. E

“…A case of idiopathic myelofibrosis (IMF) with concomitant autoimmune thrombocytopenic purpura (AITP) is reported. The literature on platelet antibodies in IMF…”
Get full text

Translating the MDS flow cytometric score into clinical practice by Heron, M, Dovern, E, Bakker-Jonges, L E, Posthuma, E F M, Brouwer, R E, Smedts, F, Batstra, M R

Get full text

Real-world costs of chronic lymphocytic leukaemia in the Netherlands by Holtzer-Goor, K.M, Bouwmans-Frijters, C.A.M, Schaafsma, M.R, de Weerdt, O, Joosten, P, Posthuma, E.F.M, Wittebol, S, Huijgens, P.C, Mattijssen, E.J.M, Vreugdenhil, G, Visser, H, Peters, W.G, Erjavec, Z, Wijermans, P.W, Daenen, S.M.G.J, van der Hem, K.G, van Oers, M.H.J, Groot, C.A. Uyl-de

“…Abstract We performed a comprehensive cost calculation identifying the main cost drivers of treatment of chronic lymphocytic leukaemia in daily practice. In…”
Get full text

Peripheral intravenous catheter-related phlebitis by van der Sar-van der Brugge, Simone, Posthuma, E F M Ward

“…Phlebitis is a very common complication of the use of intravenous catheters. Two patients with an i.v. catheter complicated by thrombophlebitis are described…”
Get more information

Gastric outlet obstruction as a presenting manifestation of systemic lupus erythematosus by Posthuma, E F, Warmerdam, P, Chandie Shaw, M P, Breedveld, F C, Macfarlane, J D, van der Sluys Veer, A, Lamers, C B

“…A patient with nausea and vomiting who subsequently proved to have systemic lupus erythematosus is described. Although gastrointestinal involvement is common…”
Get full text